The Enterprise Value as of November 2024 (TTM) for Genfit S.A. (GNFT) is 264.27M

According to Genfit S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 264.27M. This represents a change of 48.02% compared to the average of 178.53M of the last 4 quarters.

Genfit S.A. (GNFT) Historical Enterprise Value (quarterly & annually)

How has GNFT Enterprise Value performed in the past?

The mean historical Enterprise Value of Genfit S.A. over the last ten years is 327.88M. The current 264.27M Enterprise Value has changed 7.96% with respect to the historical average. Over the past ten years (40 quarters), GNFT's Enterprise Value was at its highest in in the December 2019 quarter at 595.57M. The Enterprise Value was at its lowest in in the September 2021 quarter at 13.54M.

Genfit S.A. (GNFT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genfit S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genfit S.A. (GNFT) Average Enterprise Value

How has GNFT Enterprise Value performed in the past?

The current Enterprise Value of Genfit S.A. (GNFT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Genfit S.A. (GNFT) Enterprise Value vs. Peers

How is GNFT’s Enterprise Value compared to its peers?

Genfit S.A.’s Enterprise Value is greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than ERYTECH Pharma S.A. (43.56M), greater than Eliem Therapeutics, Inc. (119.64M), greater than HCW Biologics Inc. (25.13M), greater than Molecular Partners AG (57.69M), greater than MediciNova, Inc. (38.55M), greater than Anebulo Pharmaceuticals, Inc. (45.92M), greater than Champions Oncology, Inc. (61.85M), less than Keros Therapeutics, Inc. (1.86B), less than Janux Therapeutics, Inc. (2.92B), greater than Fennec Pharmaceuticals Inc. (113.94M), less than Edgewise Therapeutics, Inc. (3.19B), less than Harmony Biosciences Holdings, Inc. (1.68B), greater than Aerovate Therapeutics, Inc. (48.13M), greater than Adagene Inc. (59.89M), greater than Acrivon Therapeutics, Inc. Common Stock (201.35M), greater than Rezolute, Inc. (236.08M), greater than AN2 Therapeutics, Inc. (5.46M),

Build a custom stock screener for Genfit S.A. (GNFT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genfit S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genfit S.A. (GNFT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genfit S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.